| URN | urn:agi-cas:53-84-9 |
|---|---|
| Total Entities | 0 |
| Connectivity | 1281 |
| Name | NAD+ |
| Description | nicotinamide-adenine-dinucleotide-anion |
| Ariadne Ontology | Biofluids assayable substances |
|---|
| Pathway | Circadian Clock |
|---|---|
| Tricarboxylic acid cycle | |
| Glucose metabolism | |
| Pentose-phosphate shunt | |
| Mannose metabolism | |
| Amino sugars synthesis | |
| Histidine metabolism | |
| Serine and Glycine metabolism | |
| Tryptophan metabolism | |
| Phenylalanine and Tyrosine metabolism | |
| Branched chain amino acids metabolism | |
| Ser/Gly/Thr/Cys metabolism | |
| Lysine metabolsm | |
| Urea cycle and arginine metabolism | |
| Alanine metabolism | |
| Aspartate metabolism | |
| Glu/Gln/Pro metabolsm | |
| Purine metabolism | |
| Nicotinate and nicotinamide metabolism | |
| Folate biosynthesis | |
| Heme oxidation | |
| Heme biosynthesis | |
| Bile acids metabolism | |
| Biosynthesis of cholesterol | |
| Metabolism of glucocorticoids and mineralcorticoids | |
| Metabolism of estrogens and androgens | |
| Arachidonic acid metabolism | |
| Metabolism of triacylglycerols | |
| ROS metabolism | |
| Fatty acid oxidation | |
| Respiratory chain and oxidative phosphorylation | |
| Metabolism of glycerophospholipids and ether lipids | |
| Bile acid metabolism (alternative pathway) | |
| Galactose metabolism | |
| Ascorbate biosyntesis | |
| Pyruvate metabolism | |
| L-sugars oxidation | |
| Vitamin A (retinol) metabolism and visual cycle | |
| Glutathione metabolism | |
| Malonate, propanoate and beta-alanine metabolism | |
| Vitamin K metabolism | |
| Caffeine metabolism | |
| Ethanol metabolism | |
| Omega-3-fatty acid metabolism | |
| Glyoxylate and glycerate metabolism | |
| D-amino acid metabolism | |
| Omega-6-fatty acid metabolism | |
| Ketonogenesis | |
| Alpha oxidation of phytanic acid | |
| Hypoxia-Induced Mitochondrial Damage | |
| Cytosolic Calcium Overload | |
| Ethanol-Induced Hepatotoxicity | |
| retinoid cycle metabolic pathway | |
| altered retinoid cycle metabolic pathway |
| Group | Biofluids assayable substances |
|---|
| MedScan ID | 1088900 |
|---|
| Alias | Enzopride |
|---|---|
| Nadida | |
| NAD+ | |
| Nadide | |
| Nadidum | |
| EINECS 200-184-4 | |
| DPN-ox | |
| DPN+ | |
| diphosphopyridine nucleotide, nicotinamide adenine dinucleotide | |
| NAD-ox | |
| Diphosphopyridine nucleotide | |
| Nicotine adenine dinucleotide | |
| diphosphopyridine dinucleotide | |
| Cozymase I | |
| diphosphopyridine nucleotide oxidized | |
| NSC 20272 | |
| Cozymase | |
| endopride | |
| pyridinium, 3-carbomoyl-1-beta-d-ribofuranosyl-, hydroxide, 5'-ester with adenosine 5'-5'-(trihydrogen | |
| pyridinium, 3-carbamoyl-1-beta-d-ribofuranosyl-, hydroxide, 5'-ester with adenosine 5'-5'- (trihydrogen pyrophosphate), inner salt | |
| Pyridine, nucleotide diphosphate | |
| Nicotinamide dinucleotide | |
| o-NAD | |
| NAD-oxidized | |
| Nicotineamide adenine dinucleotide | |
| nicotinamide-adenine-dinucleotide-anion | |
| nicotinamide adenine dinucleotide+ | |
| nicotinamide adenine dinucleotide oxidized | |
| Nicotinamide adenine dinucleotide | |
| nicotinamide adenine | |
| Oxidized diphosphopyridine nucleotide | |
| [adenine 14C]NAD | |
| 3-carbamoyl-1-beta-d-ribofuranosylpyridinium hydroxide 5' ester with adenosine 5'-pyrophosphate | |
| [U-14C]NAD | |
| [carbonyl-14C]NAD | |
| [Ado-U-14C]NAD | |
| [adenine-U-14C] NAD | |
| 3-Carbamoyl-1-beta-D-ribofuranosylpyridinium hydroxide, 5'-ester with adenosine 5'-pyrophosphate, inner salt | |
| [adenine-14C(U)]NAD | |
| [2-3H]NAD | |
| [4-3H]NAD | |
| [3H-nicotinamide]NAD | |
| [3H]-nicotinamide adenine dinucleotide | |
| [(32)P]NAD | |
| Coenzyme I | |
| [(14)C]-NAD | |
| [adenine-2,8-3H]NAD | |
| BRN 3584133 | |
| [(3)H]NAD | |
| Adenine-nicotinamide dinucleotide | |
| Codehydrogenase I | |
| Codehydrase I | |
| b-nicotinamide adenine dinucleotide | |
| beta-Nicotinamide adenine dinucleotide trihydrate | |
| beta-Nicotinamide adenine dinucleotide hydrate | |
| beta-NAD+ | |
| NAD | |
| beta-NAD | |
| beta-diphosphopyridine nucleotide, oxidized form | |
| beta-Diphosphopyridine nucleotide | |
| beta-Nicotinamide adenine dinucleotide | |
| Adenosine 5'-(trihydrogen diphosphate), P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium hydroxide, inner salt | |
| Adenosine 5'-(trihydrogen diphosphate), P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt | |
| Nadide [USAN:BAN:INN:JAN] |
| KEGG ID | C00003 |
|---|
| IUPAC Name | [[(2R,3S,4R,5R)-5-adenin-9-yl-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl phosphate |
|---|
| InChIKey | BAWFJGJZGIEFAR-NNYOXOHSSA-N |
|---|
| Rotatable Bond Count | 11 |
|---|
| ChEBI ID | 15846 |
|---|---|
| 44215 |
| CAS ID | 159929-29-0 |
|---|---|
| 30429-30-2 | |
| 53-84-9 |
| Molecular Weight | 663.425102 |
|---|
| PubChem SID | 148694 |
|---|
| PubChem CID | 5892 |
|---|
| XLogP | -6.000000 |
|---|
| Molecular Formula | C21H27N7O14P2 |
|---|
| LinkUrl | http://rgd.mcw.edu/rgdweb/ontology/annot.html?acc_id=CHEBI:15846 |
|---|